Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Melanoma 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

fludarabine 3aldesleukin 3Fluorouracil 3Cyclophosphamide 3Oxaliplatin 2Leucovorin 2Interleukin-2 2Gemcitabine 2sodium thiosulfate 1montanide ISA 51 1fludarabine phosphate 1detox adjuvant 1dehydroftorafur 1danvatirsen 1Tomography, X-Ray Computed 1Specimen Handling 1Positron-Emission Tomography 1Plicamycin 1Photography 1National Cancer Institute (U.S.) 1Mitomycin 1Microscopy, Electron 1Melphalan 1Magnetic Resonance Imaging 1MLN 8237 1Floxuridine 1Erlotinib Hydrochloride 1Electrocardiography 1Doxorubicin 1Diagnostic Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Gastrointestinal Neoplasms × detox adjuvant × Clear all
NCT00019006 2024-03-04

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

National Cancer Institute (NCI)

Phase 1 Completed
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Genetic Diseases, Inborn, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡